Holen Sie sich die Stockscreener-App
3.36
3.07%
0.10
Handel nachbörslich:
3.29
-0.07
-2.08%
Schlusskurs vom Vortag:
$3.26
Offen:
$3.3
24-Stunden-Volumen:
5.13M
Relative Volume:
1.62
Marktkapitalisierung:
$916.59M
Einnahmen:
$8.10M
Nettoeinkommen (Verlust:
$-92.72M
KGV:
-9.8824
EPS:
-0.34
Netto-Cashflow:
$-82.52M
1W Leistung:
+15.07%
1M Leistung:
+22.63%
6M Leistung:
+97.65%
1J Leistung:
+59.24%
1-Tages-Spanne:
$3.21
$3.40
1-Wochen-Bereich:
$2.82
$3.40
52-Wochen-Spanne:
$1.05
$3.40
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
Firmenname
Taysha Gene Therapies Inc
Sektor
Branche
Telefon
(214) 612-0000
Adresse
3000 PEGASUS PARK DRIVE, DALLAS
Vergleichen Sie TSHA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
3.36 | 889.31M | 8.10M | -92.72M | -82.52M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | BofA Securities | Buy |
| 2024-06-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-01 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | Herabstufung | Goldman | Buy → Neutral |
| 2022-03-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-03-01 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-18 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | Guggenheim | Buy |
| 2021-07-16 | Eingeleitet | Needham | Buy |
| 2021-06-24 | Eingeleitet | Truist | Buy |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-06-09 | Eingeleitet | Wedbush | Outperform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-05-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-05-11 | Fortgesetzt | Jefferies | Buy |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-01-05 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-10-19 | Eingeleitet | Goldman | Buy |
| 2020-10-19 | Eingeleitet | Jefferies | Buy |
| 2020-10-19 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Taysha Gene Therapies Inc Aktie (TSHA) Neueste Nachrichten
Published on: 2025-09-06 13:01:15 - Newser
Real time breakdown of Taysha Gene Therapies Inc. stock performance2025 Analyst Calls & Momentum Based Trading Signals - Newser
Is Taysha Gene Therapies Inc. benefiting from interest rate changesJuly 2025 Chart Watch & Fast Momentum Entry Tips - خودرو بانک
Is Taysha Gene Therapies Inc. subject to activist investor interestWeekly Profit Analysis & Safe Capital Growth Tips - خودرو بانک
Taysha Gene Therapies Inc. stock prediction for this weekJobs Report & Verified Short-Term Plans - Newser
Can Taysha Gene Therapies Inc. outperform under higher oil prices2025 Market Outlook & Daily Growth Stock Investment Tips - خودرو بانک
Published on: 2025-09-05 16:05:08 - Newser
What institutional flow reveals about Taysha Gene Therapies Inc.2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Taysha Gene Therapies Inc. stock entering bullish territoryQuarterly Market Review & Comprehensive Market Scan Reports - Newser
Trapped Investors in Taysha Gene Therapies Inc. Await Breakout SignalJuly 2025 Momentum & Consistent Growth Equity Picks - beatles.ru
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule 5635(c)(4) - MarketScreener
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus
Taysha Gene Therapies (TSHA) Awards Stock Options to New Employe - GuruFocus
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
225,000 Shares: Gene Therapy Biotech Taysha Grants Stock Options to Expand CNS Research Team - Stock Titan
Real time social sentiment graph for Taysha Gene Therapies Inc.Quarterly Growth Report & AI Forecast for Swing Trade Picks - Newser
How high can Taysha Gene Therapies Inc. stock goJuly 2025 Setups & High Conviction Investment Ideas - Newser
What earnings revisions data tells us about Taysha Gene Therapies Inc.Trade Risk Report & Fast Exit/Entry Strategy Plans - Newser
Taysha Gene Therapies Inc. stock retracement – recovery analysisTreasury Yields & AI Powered Trade Plan Recommendations - Newser
Taysha Gene Therapies Inc. stock volume spike explainedMarket Growth Summary & Real-Time Volume Analysis - Newser
Taysha Gene (TSHA.O) Surges 10.17% on KDJ Golden Cross and Weak Peer Performance - AInvest
Breakout Move: Can Taysha Gene Therapies Inc. sustain earnings growth2025 Support & Resistance & Technical Pattern Recognition Alerts - خودرو بانک
Is Taysha Gene Therapies Inc. a candidate for recovery playMarket Volume Report & Advanced Swing Trade Entry Plans - Newser
How to build a custom watchlist for Taysha Gene Therapies Inc.July 2025 Outlook & Reliable Intraday Trade Plans - Newser
What are Taysha Gene Therapies Inc.’s earnings expectations2025 Fundamental Recap & Reliable Entry Point Trade Alerts - خودرو بانک
Will Taysha Gene Therapies Inc. benefit from sector rotation2025 Pullback Review & Smart Investment Allocation Insights - خودرو بانک
Gains Recap: Can Taysha Gene Therapies Inc. deliver alpha2025 Retail Activity & Stock Portfolio Risk Management - خودرو بانک
How liquid is Taysha Gene Therapies Inc. stockWeekly Earnings Recap & Weekly Top Stock Performers List - خودرو بانک
What’s next for Taysha Gene Therapies Inc. stock priceJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser
Highs Report: Is Taysha Gene Therapies Inc. benefiting from interest rate changesJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - خودرو بانک
Published on: 2025-09-03 02:33:41 - Newser
Using data filters to optimize entry into Taysha Gene Therapies Inc.Dollar Strength & Reliable Breakout Forecasts - Newser
Taysha Gene Therapies Inc.’s volatility index tracking explainedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Will Taysha Gene Therapies Inc. stock go up soonJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
Using portfolio simulators with Taysha Gene Therapies Inc. includedMarket Rally & Low Drawdown Investment Ideas - Newser
Is Taysha Gene Therapies Inc. showing signs of accumulationJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser
Is Taysha Gene Therapies Inc. stock reversal real or fakeJuly 2025 Reactions & Short-Term High Return Strategies - Newser
How does Taysha Gene Therapies Inc. perform in inflationary periodsJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - خودرو بانک
Is Taysha Gene Therapies Inc. forming a reversal patternEarnings Recap Summary & Daily Stock Trend Watchlist - Newser
Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):